Literature DB >> 26309017

DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event.

Chun-Jie Huang1, Di Wu1, Faheem Ahmed Khan1, Li-Jun Huo1.   

Abstract

The discovery of the process of small ubiquitin-like modifier (SUMO)-mediated post-translational modification of targets (SUMOylation) in early 1990s proved to be a significant step ahead in understanding mechanistic regulation of proteins and their functions in diverse life processes at the cellular level. The critical step in reversing the SUMOylation pathway is its ability to be dynamically deSUMOylated by SUMO/sentrin-specific protease (SENP). This review is intended to give a brief introduction about the process of SUMOylation, different mammalian deSUMOylating enzymes with special emphasis on their regulation of ribosome biogenesis at the molecular level, and its emerging roles in mitochondrial dynamics that might reveal usefulness of SENPs for therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26309017     DOI: 10.1089/dna.2015.2933

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  13 in total

1.  The cohesion stabilizer sororin favors DNA repair and chromosome segregation during mouse oocyte meiosis.

Authors:  Chun-Jie Huang; Yi-Feng Yuan; Di Wu; Faheem Ahmed Khan; Xiao-Fei Jiao; Li-Jun Huo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-11-08       Impact factor: 2.416

2.  FOXM1 Promotes Malignant Proliferation of Esophageal Squamous Cell Carcinoma Through Transcriptional Activating CDC6.

Authors:  Xiongfeng Chen; Jingbo Chen; Xunbin Yu; Guishan Lin; Ting Chen
Journal:  DNA Cell Biol       Date:  2022-05-30       Impact factor: 3.550

3.  The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression.

Authors:  Fernando Rodríguez-Castañeda; Roza Berhanu Lemma; Ignacio Cuervo; Mads Bengtsen; Lisa Marie Moen; Marit Ledsaak; Ragnhild Eskeland; Odd Stokke Gabrielsen
Journal:  J Biol Chem       Date:  2018-08-06       Impact factor: 5.157

4.  SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver disease.

Authors:  Yuhan Liu; Fudong Yu; Yan Han; Qing Li; Zhujun Cao; Xiaogang Xiang; Shaowen Jiang; Xiaolin Wang; Jie Lu; Rongtao Lai; Hui Wang; Wei Cai; Shisan Bao; Qing Xie
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

5.  Hypothermia exerts early neuroprotective effects involving protein conjugation of SUMO‑2/3 in a rat model of middle cerebral artery occlusion.

Authors:  Gang Li; Xiaozhi Liu; Zhiguo Su; Dong Zhang
Journal:  Mol Med Rep       Date:  2017-07-15       Impact factor: 2.952

6.  Regulation of the Expression of DAPK1 by SUMO Pathway.

Authors:  Qingshui Wang; Xiuli Zhang; Ling Chen; Shuyun Weng; Yun Xia; Yan Ye; Ke Li; Ziqiang Liao; Pengchen Chen; Khaldoon Alsamman; Chen Meng; Craig Stevens; Ted R Hupp; Yao Lin
Journal:  Biomolecules       Date:  2019-04-17

7.  Lack of androgen receptor SUMOylation results in male infertility due to epididymal dysfunction.

Authors:  Fu-Ping Zhang; Marjo Malinen; Arfa Mehmood; Tiina Lehtiniemi; Tiina Jääskeläinen; Einari A Niskanen; Hanna Korhonen; Asta Laiho; Laura L Elo; Claes Ohlsson; Noora Kotaja; Matti Poutanen; Petra Sipilä; Jorma J Palvimo
Journal:  Nat Commun       Date:  2019-02-15       Impact factor: 14.919

Review 8.  Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications.

Authors:  Hong Zheng; Jinzi Wu; Zhen Jin; Liang-Jun Yan
Journal:  Biochem Insights       Date:  2016-03-23

Review 9.  The post-translational modification, SUMOylation, and cancer (Review).

Authors:  Zhi-Jian Han; Yan-Hu Feng; Bao-Hong Gu; Yu-Min Li; Hao Chen
Journal:  Int J Oncol       Date:  2018-02-22       Impact factor: 5.650

Review 10.  SUMOylation in the control of cholesterol homeostasis.

Authors:  Ana Talamillo; Leiore Ajuria; Marco Grillo; Orhi Barroso-Gomila; Ugo Mayor; Rosa Barrio
Journal:  Open Biol       Date:  2020-05-06       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.